Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_assertion type Assertion NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_head.
- NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_assertion description "[TEL-AML1 gene fusion derived by chromosomal translocation is a common acquired genetic lesion in pediatric cancer that is present in approximately 25% of B-cell precursor acute lymphoblastic leukemias, and recent evidence suggests that this recombination event may initiate leukemogenesis prenatally during fetal hemopoiesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_provenance.
- NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_assertion evidence source_evidence_literature NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_provenance.
- NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_assertion SIO_000772 10463610 NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_provenance.
- NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_assertion wasDerivedFrom befree-20150227 NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_provenance.
- NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_assertion wasGeneratedBy ECO_0000203 NP285226.RAYfsu2VejUVJBoTC31JauaK0A2tXaOBVCrb-ckzHDLxk130_provenance.